None listed
Conditions
Interventions
Intervention1: ACG 1: Approximately 0.5- 1 gm of test product is applied on whole face. frequency of application is twice in a day for the period of 28days.
Intervention2: ACG 2: Approximately 0.5- 1
Sponsors
AVT Natural Products Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1)Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 2)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) 3)Having mild to moderate acne 4)Facial skin and sebum level of forehead more than 100 µg/cm2 5)Having acne PIH dark spots
Exclusion criteria
Exclusion criteria: 1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give her/his assent by signing the consent form. 3)Taking part in another study liable to interfere with this study. 4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months). 5)Being asthmatic. 6)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex. 7)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 8)Having cutaneous hypersensitivity. 9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.10)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 11)Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 12)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted). 13)Subjects receiving steroids or antihistamine medications or receiving isotretinoin for treating other conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety, reduction in acne (live/occurring), reduction in acne PIH & sebum content on healthy female subjectsTimepoint: Baseline, 14 days, 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed